Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties

D. J. Hnatowich, G. Mardirossian, M. Rusckowski, M. Fogarasi, F. Virzi, Paul T Winnard

Research output: Contribution to journalArticle

Abstract

To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direct and one indirect method, the B72.3 and C110 IgG antibodies were radiolabeled directly via stannous ion reduction and indirectly via the hydrazino nicotinamide chelator and compared in vitro and in vivo. Antibody avidity (but not immunoreactive fraction) appeared to be independent of labeling methods for both antibodies. Following stannous ion reduction, antibodies were fragmented by denaturing SDS PAGE although only slight evidence of fragmentation was found in vivo. The direct label was instable to transchelation to cysteine and glutathione in vitro and in vivo. Following intravenous administration, urinary excretion of activity was threefold greater for the direct label and was almost exclusively labeled cysteine and glutathione. Significant differences in the biodistribution of 99mTc were also observed: liver levels were lower, kidney levels were higher and clearance of label from blood and tissues was faster for the direct label. At Day 1, tumor accumulation was threefold lower for the direct label although most normal tissues were also lower. In conclusion, when labeled to two antibodies by one direct method, 99mTc is unstable towards transchelation relative to one indirect method. These relative instabilities greatly influenced the biodistributions in mice and may influence the quality of images obtained in patients.

Original languageEnglish (US)
Pages (from-to)109-119
Number of pages11
JournalJournal of Nuclear Medicine
Volume34
Issue number1
StatePublished - 1993
Externally publishedYes

Fingerprint

Technetium
Antibodies
Glutathione
Cysteine
Ions
Antibody Affinity
Chelating Agents
Intravenous Administration
Polyacrylamide Gel Electrophoresis
Immunoglobulin G
In Vitro Techniques
Kidney
Liver
Neoplasms

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties. / Hnatowich, D. J.; Mardirossian, G.; Rusckowski, M.; Fogarasi, M.; Virzi, F.; Winnard, Paul T.

In: Journal of Nuclear Medicine, Vol. 34, No. 1, 1993, p. 109-119.

Research output: Contribution to journalArticle

Hnatowich, DJ, Mardirossian, G, Rusckowski, M, Fogarasi, M, Virzi, F & Winnard, PT 1993, 'Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties', Journal of Nuclear Medicine, vol. 34, no. 1, pp. 109-119.
Hnatowich, D. J. ; Mardirossian, G. ; Rusckowski, M. ; Fogarasi, M. ; Virzi, F. ; Winnard, Paul T. / Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties. In: Journal of Nuclear Medicine. 1993 ; Vol. 34, No. 1. pp. 109-119.
@article{f4debb294bf7489db5cf68d25ad4291c,
title = "Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties",
abstract = "To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direct and one indirect method, the B72.3 and C110 IgG antibodies were radiolabeled directly via stannous ion reduction and indirectly via the hydrazino nicotinamide chelator and compared in vitro and in vivo. Antibody avidity (but not immunoreactive fraction) appeared to be independent of labeling methods for both antibodies. Following stannous ion reduction, antibodies were fragmented by denaturing SDS PAGE although only slight evidence of fragmentation was found in vivo. The direct label was instable to transchelation to cysteine and glutathione in vitro and in vivo. Following intravenous administration, urinary excretion of activity was threefold greater for the direct label and was almost exclusively labeled cysteine and glutathione. Significant differences in the biodistribution of 99mTc were also observed: liver levels were lower, kidney levels were higher and clearance of label from blood and tissues was faster for the direct label. At Day 1, tumor accumulation was threefold lower for the direct label although most normal tissues were also lower. In conclusion, when labeled to two antibodies by one direct method, 99mTc is unstable towards transchelation relative to one indirect method. These relative instabilities greatly influenced the biodistributions in mice and may influence the quality of images obtained in patients.",
author = "Hnatowich, {D. J.} and G. Mardirossian and M. Rusckowski and M. Fogarasi and F. Virzi and Winnard, {Paul T}",
year = "1993",
language = "English (US)",
volume = "34",
pages = "109--119",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "1",

}

TY - JOUR

T1 - Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties

AU - Hnatowich, D. J.

AU - Mardirossian, G.

AU - Rusckowski, M.

AU - Fogarasi, M.

AU - Virzi, F.

AU - Winnard, Paul T

PY - 1993

Y1 - 1993

N2 - To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direct and one indirect method, the B72.3 and C110 IgG antibodies were radiolabeled directly via stannous ion reduction and indirectly via the hydrazino nicotinamide chelator and compared in vitro and in vivo. Antibody avidity (but not immunoreactive fraction) appeared to be independent of labeling methods for both antibodies. Following stannous ion reduction, antibodies were fragmented by denaturing SDS PAGE although only slight evidence of fragmentation was found in vivo. The direct label was instable to transchelation to cysteine and glutathione in vitro and in vivo. Following intravenous administration, urinary excretion of activity was threefold greater for the direct label and was almost exclusively labeled cysteine and glutathione. Significant differences in the biodistribution of 99mTc were also observed: liver levels were lower, kidney levels were higher and clearance of label from blood and tissues was faster for the direct label. At Day 1, tumor accumulation was threefold lower for the direct label although most normal tissues were also lower. In conclusion, when labeled to two antibodies by one direct method, 99mTc is unstable towards transchelation relative to one indirect method. These relative instabilities greatly influenced the biodistributions in mice and may influence the quality of images obtained in patients.

AB - To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direct and one indirect method, the B72.3 and C110 IgG antibodies were radiolabeled directly via stannous ion reduction and indirectly via the hydrazino nicotinamide chelator and compared in vitro and in vivo. Antibody avidity (but not immunoreactive fraction) appeared to be independent of labeling methods for both antibodies. Following stannous ion reduction, antibodies were fragmented by denaturing SDS PAGE although only slight evidence of fragmentation was found in vivo. The direct label was instable to transchelation to cysteine and glutathione in vitro and in vivo. Following intravenous administration, urinary excretion of activity was threefold greater for the direct label and was almost exclusively labeled cysteine and glutathione. Significant differences in the biodistribution of 99mTc were also observed: liver levels were lower, kidney levels were higher and clearance of label from blood and tissues was faster for the direct label. At Day 1, tumor accumulation was threefold lower for the direct label although most normal tissues were also lower. In conclusion, when labeled to two antibodies by one direct method, 99mTc is unstable towards transchelation relative to one indirect method. These relative instabilities greatly influenced the biodistributions in mice and may influence the quality of images obtained in patients.

UR - http://www.scopus.com/inward/record.url?scp=0027463977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027463977&partnerID=8YFLogxK

M3 - Article

C2 - 8418250

AN - SCOPUS:0027463977

VL - 34

SP - 109

EP - 119

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 1

ER -